Heron Therapeutics Reports Q2 2026 Financial Results (Press Release)

What Happened
Heron Therapeutics, Inc. (HRTX) announced its financial results for the three and six months ended June 30, 2026 via a press release dated August 10, 2026. The company filed an SEC Form 8-K on August 10, 2026 (Item 2.02) to furnish that Earnings Press Release, which is included as Exhibit 99.1 to the filing.

Key Details

• Filing date: August 10, 2026 (Form 8-K filed and furnished).
• Reporting period: Results cover the three and six months ended June 30, 2026.
• Exhibit provided: Press Release is furnished as Exhibit 99.1 to the 8-K.
• Interactive data: Inline XBRL cover page (Exhibit 104) included with the filing.

Why It Matters
Quarterly earnings releases provide revenue, profit/loss, and operational updates that investors use to assess company performance and near-term prospects. Heron’s 8-K furnishes the press release so investors and analysts can review the company’s reported results and any comments on performance, guidance, or business developments. Retail investors should read the Exhibit 99.1 press release and subsequent SEC filings for the actual figures and management discussion to evaluate impacts on HRTX’s outlook and stock prospects.